Effect of Standard vs Intensive Blood Pressure Control on the Risk of Recurrent Stroke

Effect of Standard vs Intensive Blood Pressure Control on the Risk of Recurrent Stroke

Authors

  • Priscilla Faculty of Medicine, Tarumanagara University, Special Region of Jakarta, Indonesia
  • Verawati Faculty of Medicine, Tarumanagara University, Special Region of Jakarta, Indonesia

Keywords:

Effect, Standard, Intensive, Blood Pressure Control, Risk of Recurrent Stroke

Abstract

Background: The literature surrounding blood pressure management in patients with a history of stroke has evolved significantly over the past few years, reflecting an increasing understanding of the complexities involved in optimizing treatment strategies for secondary stroke prevention. Literature Review: The literature reviewed illustrates the intricate relationship between blood pressure management and recurrent stroke risk, emphasizing the need for individualized treatment strategies. (Wang et al., 2016) provide a foundational overview of the effectiveness of various antihypertensive medications, highlighting angiotensin-converting enzyme inhibitors (ACEIs) and diuretics as key players in secondary stroke prevention. Conclusion: In conclusion, the literature presents a complex landscape of blood pressure management strategies for stroke patients, highlighting the importance of individualized approaches based on patient characteristics and specific clinical contexts. The evidence suggests that while intensive blood pressure control may offer certain protective benefits, it must be balanced with potential risks and tailored to the unique needs of each patient. Continued research is essential to refine these strategies and optimize outcomes for individuals at risk of recurrent strokes.

References

Wang, W. T., You, L. K., Chiang, C. E., Sung, S. H., Chuang, S. Y., Cheng, H. M., & Chen, C. H., 2016. Comparative Effectiveness of Blood Pressure-lowering Drugs in Patients who have Already Suffered From Stroke: Traditional and Bayesian Network Meta-analysis of Randomized Trials. ncbi.nlm.nih.gov

Charlotte Sandset, E., Sanossian, N., J. Woodhouse, L., Anderson, C., Berge, E., R. Lees, K., F. Potter, J., G. Robinson, T., Sprigg, N., M. Wardlow, J., & M.W. Bath, P., 2018. Protocol for a prospective collaborative systematic review and meta-analysis of individual patient data from randomised controlled trials of vasoactive drugs in acute stroke: the Blood pressure in Acute Stroke Collaboration, stage-3 (BASC-3). [PDF]

Sobieraj, P., Lewandowski, J., Siński, M., Symonides, B., & Gaciong, Z., 2019. Low Diastolic Blood Pressure is Not Related to Risk of First Episode of Stroke in a High‐Risk Population: A Secondary Analysis of SPRINT. ncbi.nlm.nih.gov

Camafort, M., Redón, J., Bum Pyun, W., & Coca, A., 2020. Intensive blood pressure lowering: a practical review. ncbi.nlm.nih.gov

Hsu, C. Y., L. Saver, J., Ovbiagele, B., Wu, Y. L., Cheng, C. Y., & Lee, M., 2023. Association Between Magnitude of Differential Blood Pressure Reduction and Secondary Stroke Prevention: A Meta-analysis and Meta-Regression. ncbi.nlm.nih.gov

Chen, C., Ouyang, M., Ong, S., Zhang, L., Zhang, G., Delcourt, C., Mair, G., Liu, L., Billot, L., Li, Q., Chen, X., Parsons, M., P. Broderick, J., M. Demchuk, A., M. Bath, P., A. Donnan, G., Levi, C., Chalmers, J., I. Lindley, R., O. Martins, S., M. Pontes-Neto, O., Muñoz Venturelli, P., Olavarría, V., Lavados, P., G. Robinson, T., M. Wardlaw, J., Li, G., Wang, X., Song, L., & S. Anderson, C., 2023. Effects of intensive blood pressure lowering on cerebral ischaemia in thrombolysed patients: insights from the ENCHANTED trial. ncbi.nlm.nih.gov

Downloads

Published

2024-07-10

How to Cite

Priscilla, Priscilla, and Verawati Verawati. 2024. “Effect of Standard Vs Intensive Blood Pressure Control on the Risk of Recurrent Stroke”. The International Journal of Medical Science and Health Research 2 (7): 30-42. https://doi.org/10.70070/sr7phb09.